HURA (TuHURA Biosciences) ROE % Adjusted to Book Value: -27.50% (As of Mar. 2026)


HURA TuHURA Biosciences Inc HURA
12 GF Score
Price $2.23
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences ROE % Adjusted to Book Value?

TuHURA Biosciences HURA -16.60% 12 ROE % Adjusted to Book Value is -27.50% as of Mar. 2026. GuruFocus rates HURA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

TuHURA Biosciences's ROE % for the quarter that ended in Mar. 2026 was -136.66%. TuHURA Biosciences's PB Ratio for the quarter that ended in Mar. 2026 was 4.97. TuHURA Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -27.50%.

TuHURA Biosciences ROE % Adjusted to Book Value Related Terms

TuHURA Biosciences ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences ROE % Adjusted to Book Value Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 -27.49 -77.96

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.78 -44.75 -20.37 -66.10 -27.50

HURA vs AGEN, CRBP, SPRB: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, TuHURA Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's ROE % Adjusted to Book Value falls into.


HURA
12GF Score
TuHURA Biosciences Inc HURA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences ROE % Adjusted to Book Value Calculation

TuHURA Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-169.18% / 2.17
=-77.96%

TuHURA Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-136.66% / 4.97
=-27.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -27.50% mean?
TuHURA Biosciences (HURA) has a ROE % Adjusted to Book Value of -27.50% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on TuHURA Biosciences and its competitors.
Is TuHURA Biosciences' ROE % Adjusted to Book Value too high?
TuHURA Biosciences' current ROE % Adjusted to Book Value is -27.50%. Overall, TuHURA Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' ROE % Adjusted to Book Value compare to AGEN and CRBP?
TuHURA Biosciences' ROE % Adjusted to Book Value of -27.50% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current ROE % Adjusted to Book Value is -27.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current ROE % Adjusted to Book Value of -27.50%. The current ROE % Adjusted to Book Value is -27.50%. TuHURA Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current ROE % Adjusted to Book Value is -27.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
12GF Score

Get the complete analysis for HURA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.23
Price